Simple jQuery Dropdowns

Browsing by Author Eli Lilly Australia Pty Ltd.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)
15-Sep-2006Asian outpatients with schizophrenia: A double-blind randomized comparison of quality of life and clinical outcomes for patients treated with olanzapine or haloperidolRonnachai Kongsakon; Pureza Trinidad-Oate; Haroon Rashid Chaudhry; Syed Baqar Raza; Cynthia R. Leynes; Inam Ur Rehman Khan; Hasanah Che Ismail; Benjamin Chan; Joy C. Ignacio; Sonia C. Rodriguez; Amanda J. Lowry; Alan J.M. Brnabic; Robert Buenaventura; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Cebu Doctors Hospital; Fatima Jinnah Medical College; General Hospital; St. Luke's Medical Center Quezon City; KV S.I.T.E. Hospital; School of Medical Sciences - Universiti Sains Malaysia; Hospital Permai; Jose R. Reyes Memorial Medical Center; Eli Lilly Australia Pty Ltd.; Eli Lilly (Philippines), Inc.; Mahidol University
1-May-2006A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: A 6-month studyA. W.C. Kung; E. G. Pasion; M. Sofiyan; E. M.C. Lau; B. K. Tay; K. S. Lam; K. Wilawan; B. Ongphiphadhanakul; Daniel Thiebaud; The University of Hong Kong; Our Lady of Lourdes Hospital; Kuala Lumpur Hospital; Hong Kong Orthopaedic and Osteoporosis Center for Treatment and Research; Singapore General Hospital; Changi General Hospital; Royal Thai Army; Mahidol University; Eli Lilly and Company; Eli Lilly Australia Pty Ltd.
1-Mar-2016First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results from a Randomized Phase III TrialMark Boye; Xin Wang; Vichien Srimuninnimit; Jin Hyoung Kang; Chun Ming Tsai; Mauro Orlando; Tarun Puri; Jong Seok Kim; Narayan Rajan; James Chih Hsin Yang; Eli Lilly and Company; Mahidol University; The Catholic University of Korea; National Yang-Ming University Taiwan; Eli Lilly Interamerica Inc.; Eli Lilly Australia Pty Ltd.; National Taiwan University Hospital
1-May-2011Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervixAlfonso Dueñas-González; Juan J. Zarbá; Firuza Patel; Juan C. Alcedo; Semir Beslija; Luis Casanova; Pittayapoom Pattaranutaporn; Shahid Hameed; Julie M. Blair; Helen Barraclough; Universidad Nacional Autonoma de Mexico; Medical Center; Eli Lilly Interamerica; Postgraduate Institute of Medical Education and Research; National Institute of Oncology; University of Sarajevo; Instituto Nacional de Enfermedades Neoplsicas; Mahidol University; Shaukat Khanum Memorial Cancer Hospital and Research Centre; Eli Lilly Australia Pty Ltd.